Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine
- 15 March 2006
- journal article
- research article
- Published by Elsevier BV in Drug and Alcohol Dependence
- Vol. 82 (1), 25-31
- https://doi.org/10.1016/j.drugalcdep.2005.08.005
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Relative bioavailability of different buprenorphine formulations under chronic dosing conditionsDrug and Alcohol Dependence, 2004
- Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health‐related quality of life assessmentAddiction, 2003
- Accessing opiate dependence treatment medications: buprenorphine products in an office-based settingDrug and Alcohol Dependence, 2003
- Clinical efficacy of buprenorphine: comparisons to methadone and placeboDrug and Alcohol Dependence, 2003
- Food and Drug Administration Approval of BuprenorphineNaloxone for Office Treatment of AddictionAnnals of Internal Medicine, 2003
- Buprenorphine: blending practice and researchJournal of Substance Abuse Treatment, 2002
- A Liquid Chromatographic-Electrospray Ionization-Tandem Mass Spectrometric Method for Determination of Buprenorphine, Its Metabolite, norBuprenorphine, and a Coformulant, Naloxone, That Is Suitable for in Vivo and in Vitro Metabolism StudiesAnalytical Biochemistry, 2002
- A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependenceAddiction, 2001
- Pharmacokinetic comparison of the buprenorphine sublingual liquid and tabletDrug and Alcohol Dependence, 1999
- Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid FormulationsThe Journal of Clinical Pharmacology, 1999